Could any one please tell me what is the role of the dbsnp vcf file in the GATK Base Quality Score recalibration program -> http://www.broadinstitute.org/gsa/wi..._recalibration
-
-
It's to mask out known SNPs so those positions don't get counted as mismatches / sequence errors. -
Great thanks....I have another confusion, I have noticed the presence of similar snp's multiple times in the dbsnp file, do you know if this makes any difference to the recalibration process? Also, could you please if possible direct me to the actual code(java packages) where this dbsnp file is being used so that I can understand its functionality??Originally posted by nickloman View PostComment
-
Have a dig around here
http://www.broadinstitute.org/gsa/wi..._recalibration
and
Similar SNPs or the same SNP? I don't think the presence of the same SNP would make any difference to the result, the call is either ignored or it isn't.Comment
-
I beleive same snp's, even I think it wont make any difference but i needed confirmation. And I have gone through most of these packages u posted the link for....was unable to find the one that I need.Originally posted by nickloman View PostHave a dig around here
http://www.broadinstitute.org/gsa/wi..._recalibration
and
Similar SNPs or the same SNP? I don't think the presence of the same SNP would make any difference to the result, the call is either ignored or it isn't.
Comment
-
java\src\org\broadinstitute\sting\gatk\walkers\recalibration\CountCovariatesWalker.java seems to be the relevant file...Comment
-
Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?
Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating...10-14-2026, 09:55 AM -
Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.
We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing...
Comment